Skip to main content
Top
Published in: Forensic Science, Medicine and Pathology 2/2018

01-06-2018 | Case Report

Fatal intoxication with antidepressants: a case with many culprits

Authors: Antonis Goulas, Nikolaos Raikos, Diamantis Krokos, Orthodoxia Mastrogianni, Amvrosios Orphanidis, Konstantinos Zisopoulos, Androniki Tsepa

Published in: Forensic Science, Medicine and Pathology | Issue 2/2018

Login to get access

Abstract

Serotonin-specific reuptake inhibitors (SSRIs) are generally considered safe drugs but fatal adverse effects do sometimes occur, often as a consequence of interactions with other serotonin active drugs. Polypharmacy is usually a problem that the elderly encounter, but it can also have dire consequences for young people, especially when an underlying heart condition is present. Thus, failure to diagnose heart disease and the use of contraindicated medications can be a lethal combination, irrespective of age. Here we present a case of a young adult suffering from bipolar disorder who used a combination of two SSRIs (citalopram and fluoxetine) and a monoamine oxidase inhibitor (MAO; moclobemide) with tragic consequences. The deceased also suffered from undiagnosed hypertrophic cardiomyopathy and was carrier of a genotype that may have predisposed him to increased sensitivity to SSRIs. The apparent difficulty in establishing the manner of death in this case is also discussed.
Literature
1.
go back to reference Bezchlibnyk-Butler K, Aleksic I, Kennedy SH. Citalopram--a review of pharmacological and clinical effects. J Psychiatry Neurosci. 2000;25:241–54.PubMedPubMedCentral Bezchlibnyk-Butler K, Aleksic I, Kennedy SH. Citalopram--a review of pharmacological and clinical effects. J Psychiatry Neurosci. 2000;25:241–54.PubMedPubMedCentral
3.
go back to reference Friberg LE, Isbister GK, Hackett LP, Duffull SB. The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach. J Pharmacokinet Pharmacodyn. 2005;32:571–605.CrossRefPubMed Friberg LE, Isbister GK, Hackett LP, Duffull SB. The population pharmacokinetics of citalopram after deliberate self-poisoning: a Bayesian approach. J Pharmacokinet Pharmacodyn. 2005;32:571–605.CrossRefPubMed
4.
go back to reference Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving contraindicated and inappropriate combinations of serotonergic drugs. Int J Legal Med. 2011;125:803–15.CrossRefPubMed Pilgrim JL, Gerostamoulos D, Drummer OH. Deaths involving contraindicated and inappropriate combinations of serotonergic drugs. Int J Legal Med. 2011;125:803–15.CrossRefPubMed
5.
go back to reference Pilgrim JL, Gerostamoulos D, Drummer OH. Review: pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects. Forensic Sci Med Pathol. 2011;7:162–84.CrossRefPubMed Pilgrim JL, Gerostamoulos D, Drummer OH. Review: pharmacogenetic aspects of the effect of cytochrome P450 polymorphisms on serotonergic drug metabolism, response, interactions, and adverse effects. Forensic Sci Med Pathol. 2011;7:162–84.CrossRefPubMed
7.
go back to reference Bachmann CJ, Aagaard L, Burcu M, Glaeske G, Kalverdijk LJ, Petersen I, et al. Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012. Eur Neuropsychopharmacol. 2016;26:411–9.CrossRefPubMed Bachmann CJ, Aagaard L, Burcu M, Glaeske G, Kalverdijk LJ, Petersen I, et al. Trends and patterns of antidepressant use in children and adolescents from five western countries, 2005-2012. Eur Neuropsychopharmacol. 2016;26:411–9.CrossRefPubMed
8.
go back to reference Gillman K. Moclobemide and the risk of serotonin toxicity (or serotonin syndrome). CNS Drug Rev. 2004;10:83–5.CrossRefPubMed Gillman K. Moclobemide and the risk of serotonin toxicity (or serotonin syndrome). CNS Drug Rev. 2004;10:83–5.CrossRefPubMed
9.
go back to reference Dams R, Benijts TH, Lambert WE, Van Bocxlaer JF, Van Varenbergh D, Van Peteghem C, et al. A fatal case of serotonin syndrome after combined moclobemide-citalopram intoxication. J Anal Toxicol. 2001;25:147–51.CrossRefPubMed Dams R, Benijts TH, Lambert WE, Van Bocxlaer JF, Van Varenbergh D, Van Peteghem C, et al. A fatal case of serotonin syndrome after combined moclobemide-citalopram intoxication. J Anal Toxicol. 2001;25:147–51.CrossRefPubMed
10.
go back to reference Wu ML, Deng JF. Fatal serotonin toxicity caused by moclobemide and fluoxetine overdose. Chang Gung Med J. 2011;34:644–9.PubMed Wu ML, Deng JF. Fatal serotonin toxicity caused by moclobemide and fluoxetine overdose. Chang Gung Med J. 2011;34:644–9.PubMed
11.
go back to reference Mastrogianni O, Gbandi E, Orphanidis A, Raikos N, Goutziomitrou E, Kolibianakis EM, et al. Association of the CYP2B6 c.516G>T polymorphism with high blood propofol concentrations in women from northern Greece. Drug Metab Pharmacokinet. 2014;29:215–8.CrossRefPubMed Mastrogianni O, Gbandi E, Orphanidis A, Raikos N, Goutziomitrou E, Kolibianakis EM, et al. Association of the CYP2B6 c.516G>T polymorphism with high blood propofol concentrations in women from northern Greece. Drug Metab Pharmacokinet. 2014;29:215–8.CrossRefPubMed
12.
go back to reference Papazisis G, Goulas A, Sarrigiannidis A, Bargiota S, Antoniadis D, Raikos N, et al. ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic setting. Hum Psychopharmacol. 2018; https://doi.org/10.1002/hup.2644. Papazisis G, Goulas A, Sarrigiannidis A, Bargiota S, Antoniadis D, Raikos N, et al. ABCB1 and CYP2D6 polymorphisms and treatment response of psychotic patients in a naturalistic setting. Hum Psychopharmacol. 2018; https://​doi.​org/​10.​1002/​hup.​2644.
13.
go back to reference Launiainen T, Ojanperä I. Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma. Drug Test Anal. 2014;6:308–16.CrossRefPubMed Launiainen T, Ojanperä I. Drug concentrations in post-mortem femoral blood compared with therapeutic concentrations in plasma. Drug Test Anal. 2014;6:308–16.CrossRefPubMed
14.
go back to reference Winek CL, Wahba WW, Winek CL Jr, Balzer TW. Drug and chemical blood-level data 2001. Forensic Sci Int 2001;122:107–123. Winek CL, Wahba WW, Winek CL Jr, Balzer TW. Drug and chemical blood-level data 2001. Forensic Sci Int 2001;122:107–123.
15.
go back to reference Musshoff F, Padosch S, Steinborn S, Madea B. Fatal blood and tissue concentrations of more than 200 drugs. Forensic Sci Int. 2004;142:161–210.CrossRefPubMed Musshoff F, Padosch S, Steinborn S, Madea B. Fatal blood and tissue concentrations of more than 200 drugs. Forensic Sci Int. 2004;142:161–210.CrossRefPubMed
16.
go back to reference Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care. 2012;16:R136.CrossRefPubMedPubMedCentral Schulz M, Iwersen-Bergmann S, Andresen H, Schmoldt A. Therapeutic and toxic blood concentrations of nearly 1,000 drugs and other xenobiotics. Crit Care. 2012;16:R136.CrossRefPubMedPubMedCentral
17.
go back to reference Hooten WM, Hartman WR, Black JL 3rd, Laures HJ, Walker DL. Associations between serotonin transporter gene polymorphisms and heat pain perception in adults with chronic pain. BMC Med Genet 2013;14:78. Hooten WM, Hartman WR, Black JL 3rd, Laures HJ, Walker DL. Associations between serotonin transporter gene polymorphisms and heat pain perception in adults with chronic pain. BMC Med Genet 2013;14:78.
18.
go back to reference Ojanperä I, Kriikku P, Vuori E. Fatal toxicity index of medicinal drugs based on a comprehensive toxicology database. Int J Legal Med. 2016;130:1209–16.CrossRefPubMed Ojanperä I, Kriikku P, Vuori E. Fatal toxicity index of medicinal drugs based on a comprehensive toxicology database. Int J Legal Med. 2016;130:1209–16.CrossRefPubMed
19.
go back to reference Fu K, Konrad RJ, Hardy RW, Brissie RM, Robinson CA. An unusual multiple drug intoxication case involving citalopram. J Anal Toxicol. 2000;24:648–50.CrossRefPubMed Fu K, Konrad RJ, Hardy RW, Brissie RM, Robinson CA. An unusual multiple drug intoxication case involving citalopram. J Anal Toxicol. 2000;24:648–50.CrossRefPubMed
20.
21.
go back to reference Koski A, Ojanperä I, Vuori E. Interaction of alcohol and drugs in fatal poisonings. Hum Exp Toxicol. 2003;22:281–7.CrossRefPubMed Koski A, Ojanperä I, Vuori E. Interaction of alcohol and drugs in fatal poisonings. Hum Exp Toxicol. 2003;22:281–7.CrossRefPubMed
22.
go back to reference Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry. 1996;1:453–60.PubMed Collier DA, Stöber G, Li T, Heils A, Catalano M, Di Bella D, et al. A novel functional polymorphism within the promoter of the serotonin transporter gene: possible role in susceptibility to affective disorders. Mol Psychiatry. 1996;1:453–60.PubMed
23.
go back to reference Zhu J, Klein-Fedyshin M, Stevenson JM. Serotonin transporter gene polymorphisms and selective serotonin reuptake inhibitor tolerability: review of pharmacogenetic evidence. Pharmacotherapy. 2017;37:1089–104.CrossRefPubMed Zhu J, Klein-Fedyshin M, Stevenson JM. Serotonin transporter gene polymorphisms and selective serotonin reuptake inhibitor tolerability: review of pharmacogenetic evidence. Pharmacotherapy. 2017;37:1089–104.CrossRefPubMed
24.
go back to reference Talarico G, Tosto G, Pietracupa S, Piacentini E, Canevelli M, Lenzi GL, et al. Serotonin toxicity: a short review of the literature and two case reports involving citalopram. Neurol Sci. 2011;32:507–9.CrossRefPubMed Talarico G, Tosto G, Pietracupa S, Piacentini E, Canevelli M, Lenzi GL, et al. Serotonin toxicity: a short review of the literature and two case reports involving citalopram. Neurol Sci. 2011;32:507–9.CrossRefPubMed
25.
go back to reference Unterecker S, Warrings B, Deckert J, Pfuhlmann B. Correlation of QTc interval prolongation and serum level of citalopram after intoxication--a case report. Pharmacopsychiatry. 2012;45:30–4.CrossRefPubMed Unterecker S, Warrings B, Deckert J, Pfuhlmann B. Correlation of QTc interval prolongation and serum level of citalopram after intoxication--a case report. Pharmacopsychiatry. 2012;45:30–4.CrossRefPubMed
26.
go back to reference Kronenberg S, Apter A, Brent D, Schirman S, Melhem N, Pick N, et al. Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders. J Child Adolesc Psychopharmacol. 2007;17:741–50.CrossRefPubMed Kronenberg S, Apter A, Brent D, Schirman S, Melhem N, Pick N, et al. Serotonin transporter polymorphism (5-HTTLPR) and citalopram effectiveness and side effects in children with depression and/or anxiety disorders. J Child Adolesc Psychopharmacol. 2007;17:741–50.CrossRefPubMed
27.
go back to reference Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–9.CrossRefPubMed Caspi A, Sugden K, Moffitt TE, Taylor A, Craig IW, Harrington H, et al. Influence of life stress on depression: moderation by a polymorphism in the 5-HTT gene. Science. 2003;301:386–9.CrossRefPubMed
28.
go back to reference Cao J, Hudziak JJ, Li D. Multi-cultural association of the serotonin transporter gene (SLC6A4) with substance use disorder. Neuropsychopharmacology. 2013;38:1737–47.CrossRefPubMedPubMedCentral Cao J, Hudziak JJ, Li D. Multi-cultural association of the serotonin transporter gene (SLC6A4) with substance use disorder. Neuropsychopharmacology. 2013;38:1737–47.CrossRefPubMedPubMedCentral
29.
go back to reference Andre K, Kampman O, Illi A, Viikki M, Setälä-Soikkeli E, Mononen N, et al. SERT and NET polymorphisms, temperament and antidepressant response. Nord J Psychiatry. 2015;69:531–8.CrossRefPubMed Andre K, Kampman O, Illi A, Viikki M, Setälä-Soikkeli E, Mononen N, et al. SERT and NET polymorphisms, temperament and antidepressant response. Nord J Psychiatry. 2015;69:531–8.CrossRefPubMed
30.
go back to reference Landrø NI. Towards personalized treatment of depression: a candidate gene approach. Scand J Psychol. 2014;55:219–24.CrossRefPubMed Landrø NI. Towards personalized treatment of depression: a candidate gene approach. Scand J Psychol. 2014;55:219–24.CrossRefPubMed
Metadata
Title
Fatal intoxication with antidepressants: a case with many culprits
Authors
Antonis Goulas
Nikolaos Raikos
Diamantis Krokos
Orthodoxia Mastrogianni
Amvrosios Orphanidis
Konstantinos Zisopoulos
Androniki Tsepa
Publication date
01-06-2018
Publisher
Springer US
Published in
Forensic Science, Medicine and Pathology / Issue 2/2018
Print ISSN: 1547-769X
Electronic ISSN: 1556-2891
DOI
https://doi.org/10.1007/s12024-018-9960-3

Other articles of this Issue 2/2018

Forensic Science, Medicine and Pathology 2/2018 Go to the issue